Summary
51 / 100 · Bulios Score
What speaks for it
- Revenue grew by 12% a year over the last 3 years.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 19% a year over the last 3 years.
- Analysts expect revenue to fall by 48% this fiscal year.
- It pays out more in dividends than it earns: 115% of profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.7 ZAR for 1 ZAR of yearly profit. Over the last five years it was 8.7 ZAR on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (ZAR)
Diluted EPS (ZAR)
- Analyst estimate
Revenue grew by 30% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to fall by 48%. Earnings per share fell by 19% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.88%
- Paid out of profit
- 115%
- Raised in a row
- 2 years
You receive $1.31 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
No analyst has published a price target.
50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.